MarketCapExport financials
Amgen (AMGN)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Amgen Income Statement 2025-2006 | AMGN
Brief overview of financial performance at Amgen
The figures are compared over a five-year interval. Revenue reported by Amgen was 25.4 billion dollars at the beginning of the period and 36.8 billion dollars at the end. The cumulative result was +44.6%, corresponding to roughly 7.6% per year. The company expanded at a measured pace.
Gross profit was $19.3 billion at the start and $24.7 billion at the end of the period (+28.3%). Costs absorbed a larger share of revenue over the period. Comparing the endpoints gives gross margins of 75.8% and 67.2%. The margin decline reflects a less favorable sales-and-cost structure.
The five-year EBITDA result moved by +11.8%: from 12.7 billion dollars to 14.2 billion dollars. Operating performance weakened relative to revenue. The EBITDA share of revenue changed from 50.1% to 38.8%. Cost pressure reduced operating profitability.
Over the period, net income shifted from 7.3 billion dollars to 7.7 billion dollars (+6.2%). The latest figure was the best within the selected horizon.
Market capitalization changed from $126 billion to $198 billion (+57.8%). The market broadly confirmed the positive direction of the business.
Summary assessment
The five-year picture requires weighing both strengths and weaknesses. The strongest signals are revenue expansion and a stronger final result. The weaker side of the profile includes pressure from direct costs and a declining EBITDA margin. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement Amgen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
198 B | 157 B | 155 B | 129 B | 127 B | 126 B | 137 B | 122 B | 140 B | 116 B | 116 B | 116 B | 91 B | 66.2 B | 61.8 B | 48.7 B | 50.9 B | 47.3 B | 63.6 B | - |
Shares |
538 M | 537 M | 535 M | 538 M | 570 M | 586 M | 605 M | 661 M | 731 M | 748 M | 758 M | 759 M | 753 M | 775 M | 905 M | 960 M | 1.02 B | 1.07 B | 1.12 B | - |
Historical Prices |
369 | 292 | 290 | 240 | 223 | 215 | 185 | 171 | 161 | 150 | 118 | 128 | 98.9 | 71.7 | 52.3 | 50.8 | 50.1 | 44.2 | 56.9 | 68.8 |
Net Income |
7.71 B | 4.09 B | 6.72 B | 6.55 B | 5.89 B | 7.26 B | 7.84 B | 8.39 B | 1.98 B | 7.72 B | 6.94 B | 5.16 B | 5.08 B | 4.34 B | 3.68 B | 4.63 B | 4.6 B | 4.05 B | 3.08 B | - |
Revenue |
36.8 B | 33.4 B | 28.2 B | 26.3 B | 26 B | 25.4 B | 23.4 B | 23.7 B | 22.8 B | 23 B | 21.7 B | 20.1 B | 18.7 B | 17.3 B | 15.6 B | 15.1 B | 14.6 B | 15 B | 14.8 B | - |
Cost of Revenue |
12 B | 12.9 B | 8.45 B | 6.41 B | 6.45 B | 6.16 B | 4.36 B | 4.1 B | 4.07 B | 4.16 B | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 19 B | 19.6 B | 18.8 B | 18.8 B | 17.4 B | 15.6 B | 15.3 B | 14.3 B | 13.2 B | 3.19 B | 3.2 B | - | - | - |
Operating Income |
9.08 B | 7.26 B | 7.9 B | 9.57 B | 7.64 B | 9.14 B | 9.67 B | 10.3 B | 9.97 B | 9.79 B | 8.47 B | 6.19 B | 5.87 B | 5.58 B | 4.31 B | 5.54 B | 5.51 B | 5.21 B | 3.98 B | - |
EBITDA |
14.2 B | 12.8 B | 12 B | 13 B | 11 B | 12.7 B | 11.9 B | 12.2 B | 11.9 B | 11.9 B | 10.6 B | 8.28 B | 7.15 B | 5.87 B | 5.5 B | 6.56 B | 6.56 B | 6.29 B | 5.18 B | - |
Operating Expenses |
- | - | - | - | - | - | 9.33 B | 9.38 B | 8.81 B | 9.04 B | 8.96 B | 9.45 B | 9.46 B | 8.77 B | 7.95 B | - | - | - | - | - |
General and Administrative Expenses |
7.05 B | 7.1 B | 6.18 B | 5.41 B | 5.37 B | 5.73 B | 5.15 B | 5.33 B | 4.87 B | 5.06 B | 4.85 B | 4.7 B | 5.18 B | 4.8 B | 4.49 B | 3.98 B | 3.82 B | 3.79 B | 3.36 B | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Amgen
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q4 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
538 M | 538 M | -2 M | 537 M | 537 M | 536 M | - | 535 M | 535 M | 534 M | - | 535 M | 535 M | 548 M | 534 M | 535 M | - | 548 M | 558 M | 567 M | 573 M | 577 M | 578 M | 585 M | 588 M | 590 M | 591 M | 599 M | 607 M | 622 M | 630 M | 645 M | 656 M | 707 M | 722 M | 728 M | 734 M | 737 M | 738 M | 747 M | 751 M | 753 M | 754 M | 757 M | 760 M | 761 M | 760 M | 761 M | 759 M | 757 M | 755 M | 754 M | 752 M | 751 M | 756 M | 771 M | 776 M | 791 M | 796 M | 907 M | 927 M | 933 M | 50 M | 1.02 B | 1.01 B | 1.03 B | 42 M | 1.06 B | 1.08 B |
Net Income |
1.43 B | 1.73 B | 3.25 B | 2.83 B | 746 M | -113 M | - | 2.84 B | 2.84 B | 2.84 B | - | 1.73 B | 1.48 B | 1.48 B | - | 2.14 B | - | 1.48 B | - | 1.88 B | 464 M | 1.65 B | 1.62 B | 2.02 B | 1.8 B | 1.82 B | 1.7 B | 1.97 B | 2.18 B | 1.99 B | 1.93 B | 1.86 B | 2.3 B | 2.31 B | -4.26 B | 2.02 B | 2.15 B | 2.07 B | 1.94 B | 2.02 B | 1.87 B | 1.9 B | 1.8 B | 1.86 B | 1.65 B | 1.62 B | 1.29 B | 1.24 B | 1.55 B | 1.07 B | 1.02 B | 1.37 B | 1.26 B | 1.43 B | 788 M | 1.11 B | 1.27 B | 1.18 B | 934 M | 454 M | 1.17 B | 1.12 B | 1.02 B | 1.39 B | 1.27 B | 1.02 B | -49 M | 1.12 B | 906 M |
Revenue |
9.18 B | 8.15 B | 3.85 B | 8.5 B | 8.39 B | 7.45 B | - | 6.9 B | 6.99 B | 6.1 B | - | 6.9 B | 6.59 B | 6.24 B | - | 6.65 B | - | 6.24 B | - | 6.71 B | 6.53 B | 5.9 B | - | 6.42 B | 6.21 B | 6.16 B | - | 5.74 B | 5.87 B | 5.56 B | - | 5.9 B | 6.06 B | 5.55 B | - | 5.77 B | 5.81 B | 5.46 B | - | 5.81 B | 5.69 B | 5.53 B | - | 5.72 B | 5.37 B | 5.03 B | - | 5.03 B | 5.18 B | 4.52 B | - | 4.75 B | 4.68 B | 4.24 B | - | 4.32 B | 4.48 B | 4.05 B | - | 3.94 B | 3.96 B | 3.71 B | 4.17 B | 3.81 B | 3.71 B | 3.31 B | 3.52 B | 3.88 B | 3.76 B |
Cost of Revenue |
3.01 B | 2.97 B | -1.3 B | 3.31 B | 3.24 B | 3.2 B | - | 1.81 B | 1.81 B | 1.72 B | - | 1.81 B | 1.51 B | 1.56 B | - | 1.59 B | - | 1.56 B | - | 1.61 B | 1.64 B | 1.49 B | - | 1.56 B | 1.49 B | 1.51 B | - | 1.04 B | 1.01 B | 1.06 B | - | 1.04 B | 1.02 B | 944 M | - | 990 M | 1.02 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.74 B | 4.54 B | 4.42 B | 4.38 B | 4.63 B | 4.43 B | 4.56 B | 4.23 B | 4.9 B | 4.47 B | 4.66 B | 4.4 B | 4.51 B | 4.46 B | 4.55 B | 4.2 B | 4.6 B | 4.49 B | 4.42 B | 4.22 B | 4.26 B | 4.48 B | 4.14 B | 3.84 B | 3.99 B | 3.78 B | 3.87 B | 3.27 B | 3.77 B | 3.86 B | 3.81 B | 3.41 B | 3.42 B | 3.43 B | 3.45 B | 3.15 B | 3.25 B | 3.27 B | 3.29 B | 3.05 B | 2.76 B | - | - | - | - | - | - |
Operating Income |
2.66 B | 1.18 B | 2.95 B | 2.05 B | 1.91 B | 991 M | - | 2.02 B | 2.68 B | 1.92 B | - | 2.02 B | 2.18 B | 2.5 B | - | 2.66 B | - | 2.5 B | - | 2.38 B | 828 M | 2.13 B | - | 2.45 B | 2.32 B | 2.36 B | - | 2.48 B | 2.68 B | 2.47 B | - | 2.32 B | 2.83 B | 2.73 B | - | 2.44 B | 2.7 B | 2.59 B | - | 2.53 B | 2.38 B | 2.4 B | - | 2.34 B | 2.08 B | 2.02 B | - | 1.47 B | 1.9 B | 1.36 B | - | 1.69 B | 1.55 B | 1.44 B | - | 1.42 B | 1.59 B | 1.48 B | - | 525 M | 1.33 B | 1.29 B | 831 M | 1.6 B | 1.46 B | 1.32 B | -97 M | 1.48 B | 1.18 B |
EBITDA |
3.76 B | 2.38 B | 2.55 B | 3.25 B | 3.11 B | 2.19 B | - | 2.71 B | 3.38 B | 2.61 B | - | 2.71 B | 2.8 B | 3.14 B | - | 3.29 B | - | 3.34 B | - | 3.02 B | 1.48 B | 2.97 B | - | 5.18 B | 4.15 B | 3.25 B | - | 3.98 B | 3.67 B | 2.97 B | - | 3.78 B | 3.79 B | 3.2 B | - | 3.94 B | 3.74 B | 3.12 B | - | 4.07 B | 3.42 B | 2.92 B | - | 3.9 B | 3.12 B | 2.55 B | - | 3.03 B | 2.93 B | 1.88 B | - | 2.53 B | 2.1 B | 1.72 B | - | 2.24 B | 2.12 B | 1.74 B | - | 1.32 B | 1.87 B | 1.57 B | 687 M | 1.88 B | 1.71 B | 1.59 B | 306 M | 1.48 B | 1.18 B |
General and Administrative Expenses |
1.69 B | 1.69 B | 961 M | 1.62 B | 1.78 B | 1.81 B | - | 1.35 B | 1.29 B | 1.26 B | - | 1.35 B | 1.33 B | 1.23 B | - | 1.29 B | - | 1.23 B | - | 1.3 B | 1.38 B | 1.25 B | - | 1.35 B | 1.3 B | 1.32 B | - | 1.22 B | 1.26 B | 1.15 B | - | 1.29 B | 1.35 B | 1.13 B | - | 1.17 B | 1.21 B | 1.06 B | - | 1.24 B | 1.29 B | 1.2 B | - | 1.24 B | 1.16 B | 1.03 B | - | 1.21 B | 1.14 B | 1.02 B | - | 1.25 B | 1.26 B | 1.16 B | - | 1.13 B | 1.23 B | 1.08 B | - | 1.12 B | 1.13 B | 1.02 B | 1.15 B | 932 M | 910 M | 798 M | 683 M | 900 M | 904 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Amgen (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Russia
USA
Canada
Niderland
France
Israel
Australia
Danmark
Irlanda
